OVID THERAPEUTICS INC (OVID)

US6904691010 - Common Stock

3.07  +0.02 (+0.66%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
391.70K1.50M208.40M12.60M0.00
Operating Expenses
59.67M57.10M84.20M94.00M61.40M
Research and Development
28.59M24.60M46.90M63.40M42.20M
Selling, General, and Administrative Expenses
31.09M32.40M37.20M30.60M19.30M
Operating Income
-59.28M-55.50M124.20M-81.40M-61.40M
Interest Income/Expense
6.94M1.40M0.00400.00K900.00K
Other Income/Expense
N/A-500.00KN/AN/AN/A
Income Before Taxes
-52.34M-54.20M124.20M-81.00M-60.50M
Income Tax
N/A0.001.30MN/AN/A
Net Income
-52.34M-54.20M119.80M-81.00M-60.50M
EBITDA
-58.71M-55.00M124.40M-81.10M-61.10M
 
Per Share Data
EPS Diluted Total Ops
-0.74-0.771.76-1.39-1.54
Non GAAP EPS
-0.75-0.772.03-1.40-1.58
 
Statistics
Profit Margin
-13362.00%-3613.33%57.49%-642.86%N/A
Operating Profit Margin
-15134.40%-3700.00%59.60%-646.03%N/A

All data in USD

Charts